arrow
N

Nagi S. El Saghir

american university of beirut
H指数:35
被引数:7,352

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world prevalence of PD-L1 positivity in early-stage/metastatic triple-negative breast cancer: primary results and pathology insights from the global retrospective observational VANESSA study

早期/转移性三阴性乳腺癌中PD-L1阳性的真实世界患病率:全球回顾性观察性VANESSA研究的主要结果及病理学见解

2026-02-220
OAAI
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

6th和7th晚期乳腺癌管理国际共识指南 (ABC指南6和7)

BREAST
IF7.9
2024-08-0122
OAAI
Tailoring neo/adjuvant systemic therapy in breast cancer: The advent of a personalized approach-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations

定制乳腺癌的新/辅助系统治疗: 个性化方法的出现-乳腺妇科和免疫肿瘤学国际癌症会议 (BGICC) 共识和建议

CANCER
IF5.1
2024-07-100
PRE
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

第五届ESO-ESMO晚期乳腺癌国际共识指南 (ABC 5)

2020-12-01860
OAAI
Breast cancer treatment: A phased approach to implementation

乳腺癌治疗: 分阶段实施

CANCER
IF5.1
2020-04-2996
OAAI
Enhancing global access to cancer medicines

加强全球癌症药物的获取

2020-02-18136
OAAI
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

第4届ESO-ESMO晚期乳腺癌国际共识指南 (ABC 4)

2018-08-01859
OAAI